Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 546227Generated: November 1, 2026

Ethyl Acetate → HCID 67188846, compound

https://huagongshe.com/reaction/546227

Reaction equation

Participants

RoleNameHCIDCharge
ReactantEthyl AcetateHCID 8857—
ReactantHexamethyldisilazaneHCID 13838—
Reactant(Bromomethyl)cyclobutaneHCID 2734658—
ReactantHCID 67190452HCID 67190452—
ReactantButyllithiumHCID 178418339—
SolventTetrahydrofuranHCID 8028—
ProductHCID 67188846HCID 6718884629%

Reaction Conditions

Temperature-78 °C

Reaction Steps

In a two-necked round bottom flask under argon was placed dry tetrahydrofuran (20 mL) and 1,1,1,3,3,3-hexamethyldisilazane (1.42 mL, 6.72 mmol). This solution was then cooled to −78° C. and treated dropwise with a solution of n-butyl lithium (2.5 M solution in hexanes, 2.60 mL, 6.42 mmol). It was then stirred at −78° C. for 15 min. To this was then slowly added a solution of 2-(3-chloro-4-methylsulfanyl-phenyl)-N-((1R,2R)-2-hydroxy-1-methyl-2-phenyl-ethyl)-N-methyl-acetamide (prepared as in PCT WO 2004/052869 A1, Example 1, 1.06 g, 2.92 mmol) in dry tetrahydrofuran (20 mL). The solution was then warmed to 0° C. and stirred for 1 h. After this time the yellow solution was then cooled back to −78° C. and treated dropwise with a solution of bromomethyl-cyclobutane (610 mg, 4.09 mmol) in 2,3-dimethyl-3,4,5,6-tetrahydro-2(1H)-pyrimidinone (0.80 mL, 6.42 mmol). The reaction was then warmed and stirred at 0° C. for 16 h. The reaction was then diluted with ethyl acetate (120 mL) and transferred to a separatory funnel and washed with a saturated aqueous ammonium chloride solution (40 mL) and then a saturated aqueous brine solution (40 mL). The organic layers were combined and then dried over sodium sulfate and concentrated in vacuo with silica gel (4 g) and purified on Biotage Flash chromatography system (40M column, silica gel, 50% ethyl acetate/hexanes to 80% ethyl acetate/hexanes) to afford (R)-2-(3-chloro-4-methylsulfanyl-phenyl)-3-cyclobutyl-N-((1R,2R)-2-hydroxy-1-methyl-2-phenyl-ethyl)-N-methyl-propionamide (361 mg, 29%).

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS07935699B2
Source datasetuspto-grants-2011_05
ORD IDord-c33e9030fa0d4a14a6050709169921e0
Source noteuspto-grants-2011_05